The newly independent spin-off from chemical company Solvay is driving sustainable beauty with the expansion of its Boston Biotechnology Lab to grow R&I in the US. Originally launched through a partnership with Ginkgo Bioworks in April 2023, the now-acquired lab is central to Syensqo’s 12 other R&I centers. The Cambridge Lab, which focuses on microbial strain engineering and enzyme discovery, uses modern methods to convert renewable feedstocks into biobased and recycled cosmetic ingredients.
